Levetiracetam Tecnigen

Levetiracetam, the active ingredient in Levetiracetam Tecnigen, is a antiepileptic presented as an oral tablet for oral use. It is prescribed to manage partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Tecnigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic agent that reduces abnormal neuronal firing in the brain. - Partial‑onset seizures: lowers seizure frequency in focal epilepsy. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: diminishes rapid muscle jerks associated with certain epilepsy syndromes.

Levetiracetam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: persistent tiredness not relieved by rest. - Headache: mild to moderate cranial pain. - Irritability: mood changes or increased agitation. - Nausea: feeling of queasiness or upset stomach. - Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood disorders: depression, anxiety, or suicidal thoughts. - Hematologic changes: low blood cell counts. - Hepatic dysfunction: elevated liver enzymes. - Stevens‑Johnson syndrome: severe skin blistering. - Multiorgan failure: rare but life‑threatening systemic involvement.

Before initiating therapy, consider the following safety measures. - Renal function: adjust dose in patients with impaired kidney function. - Psychiatric history: monitor for mood changes or suicidal ideation. - Pregnancy: discuss potential risks with a healthcare professional, as safety data are limited. - Breastfeeding: evaluate benefits versus potential infant exposure. - Concomitant CNS depressants: use with caution as additive sedation may occur. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: can lower levetiracetam concentrations. - Phenytoin: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Sedative antihistamines: increased drowsiness risk. - Opioids: potential additive sedation. - Other antiepileptics: monitor seizure control and side‑effect profile.